Work

ABCL-316 Health-Related Quality of Life and Tolerability in Patients With/Without Skin Toxicity During Loncastuximab Tesirine Treatment in a Phase 2 Clinical Trial (LOTIS-2)

Year: 2022

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)01526-9

Authors: Alexander Spira, Xiaolei Zhou, Laura Liao, Eric Yu, Lei Chen, Augustine Lau, Ying Wang, Ari Gnanasakthy, John Radford, Mehdi Hamadani

Institutions: Virginia Cancer Specialists, RTI Health Solutions, University of Manchester, The Christie NHS Foundation Trust, Medical College of Wisconsin

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4296529460

FWCI:

Cites:

Cited by:

Related to: 10